Ritholtz Wealth Management
AUPH icon

Ritholtz Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Ritholtz Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.57M Buy
405,562
+42,506
+12% +$678K 0.09% 148
2026
Q2 		$6.16M Buy
363,056
+48,630
+15% +$777K 0.09% 135
2026
Q1 		$4.66M Buy
314,426
+55,610
+21% +$813K 0.08% 178
2025
Q4 		$4.13M Buy
258,816
+174,301
+206% +$2.47M 0.08% 183
2025
Q3 		$934K Buy
+84,515
New +$923K 0.02% 519

Other funds holding AUPH

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
O'Shaughnessy Asset Management
O'Shaughnessy Asset Management Stamford, Connecticut $23.6B AUM 34.05% 1-Year Est. Return
Hillsdale Investment Management
Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Ritholtz Wealth Management's AUPH Position: Q3 2026 in Review

Ritholtz Wealth Management increased its Aurinia Pharmaceuticals (AUPH) stake by 12% in Q3 2026, buying an estimated $678K and bringing the position to 405,562 shares worth $6.57M. The position accounts for 0.09% of the portfolio, ranked #148.

Ritholtz Wealth Management first reported a position in AUPH in Q3 2025 and has held it in 5 quarters since. 173 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • Ritholtz Wealth Management held 405,562 shares of Aurinia Pharmaceuticals worth $6.57M as of Q3 2026.
  • Ritholtz Wealth Management bought 42,506 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $678K.
  • Aurinia Pharmaceuticals made up 0.09% of Ritholtz Wealth Management's portfolio in Q3 2026, its #148 holding.
  • Ritholtz Wealth Management first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 173 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Ritholtz Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.